APA (7th ed.) Citation

Tartour, E., Mehtali, M., Sastre-Garau, X., Joyeux, I., Mathiot, C., Pleau, J. M., . . . Dorval, T. (2000). Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: Clinical and immunological findings. British Journal of Cancer, 83(11), 1454. https://doi.org/10.1054/bjoc.2000.1492

Chicago Style (17th ed.) Citation

Tartour, E., et al. "Phase I Clinical Trial with IL-2-transfected Xenogeneic Cells Administered in Subcutaneous Metastatic Tumours: Clinical and Immunological Findings." British Journal of Cancer 83, no. 11 (2000): 1454. https://doi.org/10.1054/bjoc.2000.1492.

MLA (9th ed.) Citation

Tartour, E., et al. "Phase I Clinical Trial with IL-2-transfected Xenogeneic Cells Administered in Subcutaneous Metastatic Tumours: Clinical and Immunological Findings." British Journal of Cancer, vol. 83, no. 11, 2000, p. 1454, https://doi.org/10.1054/bjoc.2000.1492.